Invention Grant
- Patent Title: Compounds as diacylglycerol acyltransferase inhibitors
-
Application No.: US15839997Application Date: 2017-12-13
-
Publication No.: US10174049B2Publication Date: 2019-01-08
- Inventor: Mui Cheung , Raghuram S. Tangirala
- Applicant: GlaxoSmithKline LLC
- Applicant Address: US DE Wilmington, New Castle
- Assignee: Glaxosmithkline LLC
- Current Assignee: Glaxosmithkline LLC
- Current Assignee Address: US DE Wilmington, New Castle
- Agency: Wolf, Greenfield & Sacks, P.C.
- Priority: IN3593/DEL/2012 20121123; IN750/DEL/2013 20130314
- Main IPC: C07D209/40
- IPC: C07D209/40 ; C07D498/04 ; C07D519/00

Abstract:
This invention relates to methods for the preparation of a compound which is an inhibitor of acyl coenzyme A: diacylglycerol acyltransferase 1 (DGAT-1).
Public/Granted literature
- US20180099979A1 NOVEL COMPOUNDS AS DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS Public/Granted day:2018-04-12
Information query